Selection of endpoints in clinical studies of enzyme replacement therapy in lysosomal storage disorders - Commentary
dc.contributor.author | Hopwood, J. | |
dc.date.issued | 2001 | |
dc.identifier.citation | Journal of Inherited Metabolic Disease, 2001; 24(SUPPL. 2):45-46 | |
dc.identifier.doi | 10.1023/A:1012459521922 | |
dc.identifier.issn | 0141-8955 | |
dc.identifier.issn | 1573-2665 | |
dc.identifier.uri | http://hdl.handle.net/2440/32945 | |
dc.language.iso | en | |
dc.publisher | Kluwer Academic Publ | |
dc.rights | © 2001 SSIEM and Kluwer Academic Publishers | |
dc.source.uri | http://dx.doi.org/10.1023/a:1012459521922 | |
dc.title | Selection of endpoints in clinical studies of enzyme replacement therapy in lysosomal storage disorders - Commentary | |
dc.type | Journal article | |
pubs.publication-status | Published |